Repository logo
 

Tumor-induced stromal reprogramming drives lymph node transformation.

Accepted version
Peer-reviewed

Repository DOI


Type

Article

Change log

Authors

Riedel, Angela 
Haas, Lisa 
Hall, Benjamin A 
Shields, Jacqueline 

Abstract

Lymph node (LN) stromal cells, particularly fibroblastic reticular cells (FRCs), provide critical structural support and regulate immunity, tolerance and the transport properties of LNs. For many tumors, metastasis to the LNs is predictive of poor prognosis. However, the stromal contribution to the evolving microenvironment of tumor-draining LNs (TDLNs) remains poorly understood. Here we found that FRCs specifically of TDLNs proliferated in response to tumor-derived cues and that the network they formed was remodeled. Comparative transcriptional analysis of FRCs from non-draining LNs and TDLNs demonstrated reprogramming of key pathways, including matrix remodeling, chemokine and/or cytokine signaling, and immunological functions such as the recruitment, migration and activation of leukocytes. In particular, downregulation of the expression of FRC-derived chemokine CCL21 and cytokine IL-7 were accompanied by altered composition and aberrant localization of immune-cell populations. Our data indicate that following exposure to tumor-derived factors, the stroma of TDLNs adapts on multiple levels to exhibit features typically associated with immunosuppression.

Description

Keywords

Animals, Cell Differentiation, Cell Movement, Cell Transformation, Neoplastic, Cellular Reprogramming, Chemokine CCL21, Cytokines, Extracellular Matrix, Female, Fibroblasts, Interleukin-7, Lymph Nodes, Melanoma, Experimental, Mice, Mice, Inbred C57BL, Neoplasm Metastasis, Neoplasms, Signal Transduction, Stromal Cells, Tissue Array Analysis, Transcriptome, Tumor Microenvironment

Journal Title

Nat Immunol

Conference Name

Journal ISSN

1529-2908
1529-2916

Volume Title

17

Publisher

Springer Science and Business Media LLC
Sponsorship
MRC (unknown)
MRC (MR/N501876/1)
Medical Research Council (MC_UU_12022/9)
Medical Research Council (MC_UU_12022/5)
MRC
Royal Society (Paul Instrument Fund) (UF130039)
This research was supported by the CIMR Flow Cytometry Core Facility. We wish to thank all FCCF staff members for their advice and support in flow cytometry and cell sorting applications. Work was supported by Medical Research Council funding. BAH is supported by the Royal Society (University Research Fellowship).